Innovations in Oral Solid Drug Delivery: Advances in Nanotechnology, Controlled Formulations & peptide delivery Market Report Now Available on ReportsandReports
The loss of patent protection for blockbuster drugs peaking between 2007-2012, loss of patent protection for the first-generation of OSDDS in the last few years, the dearth of NCEs coming through the pipeline and puts new developments in the context of a market that is seeing a decline in its value in some therapeutic areas.
View full press release